GlassScriptPhysician profile
Hannah Tulkoff
NPI 1588272454
$1,477.71
in general payments reported to CMS, 2019-2025
19 companies · $80.96 in 2025
The $80.96 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $638 · 2022: $314 · 2023: $310 · 2024: $135 · 2025: $80.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $319.27 | 2021-2023 | |
| Astellas Pharma US INC | $193.04 | 2022-2025 | Veozah |
| Daiichi Sankyo INC. | $146.01 | 2021-2022 | |
| Exeltis, USA INC. | $141.03 | 2021-2024 | Slynd |
| Aspira Women'S Health INC | $118.95 | 2021-2023 | Ova1 |
| Amgen INC. | $106.15 | 2021-2024 | Prolia, Evenity |
| Renovia INC | $97.64 | 2021 | |
| Therapeuticsmd, INC. | $84.71 | 2021-2022 | |
| Avion Pharmaceuticals | $47.28 | 2021-2022 | |
| Coopersurgical, INC. | $46.42 | 2021-2023 | Summit Doppler |
| Millicent US INC | $38.12 | 2024-2025 | Femlyv, Femring, Intrarosa |
| Bayer Healthcare Pharmaceuticals INC. | $24.69 | 2023 | |
| Pfizer INC. | $23.57 | 2021 | |
| Scynexis, INC. | $19.72 | 2022 | |
| Sumitomo Pharma America, INC. | $17.25 | 2023 | Myfembree |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.70 | 2023 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $13.04 | 2022 | |
| Mylan Pharmaceuticals INC. | $12.34 | 2021 | |
| Evofem Biosciences, INC. | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Tulkoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.